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Conclusions: The ratio of OxLDL to HDL seems to be an important predictor of subse-
quent MI in patients with UCAD.
POSTER SESSION
1064 
Pathogenesis and Treatment of the 
Atherosclerotic Plaque
Monday, March 08, 2004, 9:00 a.m.-11:00 a.m.
Morial Convention Center, Hall G
Presentation Hour: 9:00 a.m.-10:00 a.m.
1064-178 A Novel Oral Neutrophil Elastase Inhibitor, ONO-6818, 
Suppressed Early Atherosclerotic Plaque Formation in 
Apolipoprotein E-Knockout Mice
Yoshitaka Iso, Hiroshi Suzuki, Teruko Soda, Fumitaka Tsunoda, Takatoshi Sato, Makoto 
Shoji, Shinji Koba, Eiichi Geshi, Takashi Katagoro, Showa University School of Medicine, 
Tokyo, Japan
Objective: Proteolysis and elastolysis contribute to the development of atherosclerosis.
Neutrophil elastase (NE) can degrade not only elastin but also collagens, fibronectin, and
proteoglycans, and it is predominantly present in neutrophils. However, recent studies
indicated the expression of NE in atheroma-related cells. Therefore, we hypothesized NE
inhibition prevented atherogenesis, and examined whether ONO-6818, an orally active
inhibitor of NE, limited atherosclerotic lesion in apolipoprotein E-knockout mice (ApoE-
KO mice). Methods and Results: ApoE-KO mice (8 weeks of age) were fed a normal
chow diet, and euthanized at the age of 12 weeks. They were divided into 2 groups; (1)
control group (n=8, oral administration of saline) (2) treatment group (n=8, oral adminis-
tration of 100mg/kg ONO-6818 for 4weeks). Plasma cholesterol levels were not signifi-
cantly different between the two groups at the age of 12 weeks. Histological analysis of
atherosclerotic lesions in the aortic root was performed using oil red O stained-sections.
Plaque area was significantly reduced in ApoE-KO mice treated with ONO-6818 com-
pared to the control group (9377 +/- 2078 µm2 versus 28464 +/- 7613 µm2, p=0.02). In
immunohistochemical study, the percent area of macrophage accumulation to the total
cross-sectional vessel wall area was smaller in ApoE-KO mice treated with ONO-6818
than the control group (1.0 +/- 0.2% versus 2.8 +/- 0.9%, p=0.07). The abdominal aortas
of ApoE-KO mice were used for RT-PCR analysis of eNOS mRNA. ONO-6818 prevented
downregulation of eNOS mRNA expression in ApoE-KO mice compared to the controls.
Conclusions: NE inhibitor suppressed early atherosclerotic plaque formation and pro-
tected endothelial function in ApoE-KO mice. These results suggested that NE could be a
new therapeutic target for atherogenesis.
1064-179 Mice Deficient in Leptin or the Leptin Receptor Exhibit 
Reduced Neointima Formation Following Vascular 
Injury
Yuechun Shen, Peter F. Bodary, Daniel T. Eitzman, University of Michigan, Ann Arbor, MI
Background: Elevated levels of plasma leptin have been identified as an independent
risk factor for cardiovascular disease, although the mechanism by which leptin increases
this risk is unknown. We hypothesize that leptin may contribute to vascular disease
through effects on vascular remodeling.
Methods and results: A mouse model of femoral arterial wire injury was used that
induces endothelial damage followed by intimal hyperplasia. We induced arterial injury in
wild type (Lep+/+) (n=8), leptin deficient (Lep-/-) (n=13) and leptin receptor deficient
(LepR-/-) (n=9) mice. Four weeks after injury, the intima/media ratios (I/Ms) of Lep-/- and
LepR-/- mice were 0.80±0.14 and 0.55±0.20, which were significantly reduced compared
to Lep+/+ mice (1.50±0.22) (p<0.01 and <0.02, respectively). To further establish that
leptin was responsible for the altered neointima formation, leptin was replaced in Lep-/-
mice by daily peritoneal injection beginning one day prior to injury until sacrifice. The I/Ms
of Lep-/- mice (n=8) receiving leptin treatment were significantly higher (1.44±0.18) than
Lep-/- mice described in the original cohort (p<0.02). Mice were also treated with an ade-
novirus, expressing murine leptin on the RSV promoter, one day following injury. The I/Ms
of Lep-/- mice (n=6) receiving ad-leptin were 2.04±0.27, which were significantly higher
compared to the I/Ms of the control Lep-/- mice (p<0.004). The I/Ms of LepR-/- mice (n=4)
receiving ad-leptin were 0.50±0.19, which were not different from the I/Ms in the original
group of LepR-/- mice.
Conclusion: These observations demonstrate that mice lacking leptin or the leptin
receptor are protected from neointima formation following vascular injury and suggest
that leptin may play a role in atherosclerosis by promoting lesion growth.
1064-180 Splenectomy and Adoptive Transfer of Splenocytes 
Reveal a Critical Role for Spleen in Mediating Athero-
Protective Effects of Immunization With Apolipoprotein 
B-100-Related Peptide Sequence in Apo E (-/-) Mice
Kuang-Yuh Chyu, Stephanie M. Babbidge, Paul C. Dimayuga, Juliana Yano, Jan Nilsson, 
Bojan Cercek, Prediman K. Shah, Gunilla Nordin Fredrikson, Cedars-Sinai Medical 
Center, Los Angeles, CA, Lund University, Malmo, Sweden
Background: We have previously reported athero-protective effects of immunizing
hypercholesterolemic apo E (-/-) mice with single or mixture of human apo B 100 related
peptides. One such peptide is peptide 2 (ATRFKHLRKYTYNYEAESSS, 95% homology
with murine apo B 100). In this study, we sought to determine the role of spleen in medi-
ating athero-protective effects of peptide 2 immunization.
Methods and Results: Male apo E (-/-) mice were immunized with 33 mcg of peptide 2
at 6 weeks of age and boosted at 9 weeks with Alum as adjuvant. Control group received
Alum only. At 12 weeks splenocytes were harvested, pooled and injected into non-immu-
nized apo E (-/-) mice via tail vein. Both donor and recipient groups were fed high choles-
terol diet until sacrifice at 25 weeks. Splenectomy abolished athero-protective effect of
peptide 2 immunization; whereas adoptive transfer of splenocytes from peptide 2 immu-
nized mice reduced atherosclerosis and cholesterol levels in recipient unimmunized
mice. (Table)
Conclusion: Our data provide proof of principle that spleen plays an important role in
mediating the atheroprotective effects of immunization with a single apo B 100 related
peptide in apo E (-/-) mice. 
When compared to Alum recipient group “*” p < 0.05 and “#” p=0.07 by t-test
1064-181 Distinct Signaling Pathways Mediate Protease Activated 
Receptor-Dependent Endothelial Exocytosis
John H. Cleator, Douglas E. Vaughan, Heidi E. Hamm, Vanderbilt University, Nashville, 
TN
Thrombin stimulation of the release von Willebrand Factor (vWF) and P-selectin from
endothelial cells results in propagation of thrombotic events (vWF- mediated platelet
adhesion and aggregation) and adhesion of neutrophils through P-selectin.The purpose
of this study is to determine which Protease Activated Receptors are responsible for
mediating thrombin-induced release of vWF and P-selectin from human umbilical vein
endothelial cells (HUVEC). HUVEC were stimulated with thrombin, specific PAR-activat-
ing peptides (PAR-AP) or histamine and released vWF was measured in the media
(ELISA), while P-selectin was measured on the cell membranes using a cell-based
ELISA. PAR1-AP and PAR2-AP stimulation of vWF release was less effective when com-
pared to either thrombin or histamine stimulation. However, PAR1-AP stimulation of P-
selectin was as efficacious as histamine or thrombin stimulation. In contrast, PAR2-AP
was significantly less efficacious in stimulating the release of P-selectin than vWF. PAR2-
AP stimulation of mobilization of intracellular Ca2+ was nearly identical to PAR1-AP or
thrombin stimulation of mobilization of intracellular Ca2+. Calcium chelation with BAPTA
nearly completely inhibited thrombin-mediated release of vWF while only inhibiting 50-
60% of thrombin-mediated cell surface expression of P-selectin, suggesting an additional
Ca2+-independent pathway involved in release of P-selectin. Furthermore, pertussis toxin
inhibited the release of vWF, while not effecting P-selectin release, implicating Gi/o in
mediating the release of vWF, but not P-selectin. Immunostaining of P-selectin and vWF
demonstrated co-localization of the two proteins in characteristic Weibel-Palade bodies.
Differential signaling and co-localization of P-selectin with vWF suggest PARs stimulate
the differential release of distinct fractions of Weibel-Palade bodies. Selective pharmaco-
logical targeting of specific PARs and G proteins provides a novel therapeutic strategy for
altering the hemostatic and inflammatory balance of specific vascular beds.
1064-182 Gene Transfer of an ApoA-I Mimetic Peptide Reduces 
Atherosclerosis in Mice
Peter F. Bodary, Yuechun Shen, Randal J. Westrick, Narendra D. Lalwani, Sandra L. 
Drake, Jean-Louis H. Dasseux, Daniel T. Eitzman, University of Michigan, Ann Arbor, MI, 
Esperion Therapeutics, Inc., Ann Arbor, MI
Background. Apolipoprotein A-I (ApoA-I) has been shown to be protective against vas-
cular disease in animal models. The development of peptide-based mimetics of ApoA-1
may provide a particularly useful therapy for patients with atherosclerotic vascular dis-
ease. The goal of this study was to assess the effect of a novel ApoA-I peptide analogue
(ESP 24218, Esperion Therapeutics) designed to activate LCAT and promote reverse
lipid transport (RLT).
Methods and results. Nine week old male mice deficient in the LDL receptor were
begun on a western chow diet to accelerate atherogenesis. At 14 weeks of age, mice
were injected intravenously with saline (n=9) or a recombinant adenovirus expressing
either wild-type ApoA-I (n=9), a 22 amino acid ApoA-I peptide analogue, ESP 24218,
(n=10) or a 22 amino acid control peptide (n=10). At 18 weeks of age, mice were sacri-
ficed and the atherosclerotic surface area was quantified in the aortic arch. The amount
of atherosclerosis was significantly lower in mice expressing either wild-type ApoA-I
Death MI
OxLDL <median (n=206) 8 (4%) 19 (9%)
>median (n=226) 9 (4%) Ns 38 (17%) P=0.02
OxLDL/HDL <median (n=208) 9 (4%) 18 (9%)
>median (n=208) 6 (3%) Ns 37 (18%) P=0.006
LDL <median (n=189) 5 (3%) 26 (14%)
>median (n=197) 9 (5%) Ns 25 (13%) Ns
Cholesterol
(mg/dl)
Aortic plaque
(% area)
Aortic sinus 
plaque size 
(mm sq)
MOMA 
immunoreactivity 
(% plaque)
Alum donor, n=4 1285±114 5.6±5.3 0.55±0.05 4.3±4.6
P2 donor, n=9 910±459 3.0±1.7 0.45±0.18 4.2±3.5
Alum recipient, n=10 941±328 5.1±3.0 0.46±0.15 4.8±3.0
P2 recipient, n=9 560±239* 2.1±1.8* 0.33±0.13# 4.7±5.1
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(13.85 mm2) or ESP 24218 (11.7 mm2) compared to mice receiving only saline injections
(41.3 mm2)(p<0.02 for both comparisons). Atherosclerosis in mice expressing the control
peptide (30.8 mm2) was not significantly different than in mice receiving only the saline
injection (p=ns). Conclusion. These results demonstrate an atheroprotective effect of
ESP 24218, a 22 amino acid peptide designed to mimic the activity of ApoA-I, in mice.
1064-183 Endothelial Function and Carotid Intima-Media 
Thickness in Young Healthy Subjects Among 
Endothelial Nitric Oxide Synthase Polymorphisms
Umberto Paradossi, Enrica Ciofini, Simona Storti, Nicoletta Botto, Andrea Biagini, Maria 
Giovanna Colombo, CNR Institute of Clinical Physiology, G. Pasquinucci Hospital, 
Massa, Italy
Background: To assess the role of the endothelial nitric oxide synthase (eNOS) gene
variants as risk factors for early atherosclerosis, we sought to investigate whether two
polymorphisms located in the exon 7 (Glu298→Asp) and in the promoter region (T-
786→C) of the eNOS gene were associated with functional changes in the endothelium,
and carotid intima-media thickness (IMT).
Methods: Endothelium-dependent flow-mediated brachial artery dilation (FMD), endot-
helium-independent dilation response to glyceryl trinitrate (GTN), and carotid IMT were
assessed by high resolution ultrasound in 98 healthy young non smoker subjects
(29.8±0.5 years) genotyped for the eNOS Glu298→Asp and T-786→C polymorphisms.
Results: Carotid IMT was inversely related to FMD by univariate analysis (r=-0.29,
p=0.003) and after adjustment for possible confounders in all the subjects (p=0.03). In
comparison to Glu298 homozygotes, Asp/Asp carriers displayed a significantly lower
FMD (Glu/Glu: 15.2%±1.2% vs Asp/Asp: 9.4%±1.7%, p=0.01), while FMD was unaf-
fected by the T-786→C variant (TT: 14.6%±1.1%, TC: 12.2%±0.8%, and CC:
12.0%±1.6%, p=0.18). Neither the Glu298→Asp nor the T-786→C polymorphisms influ-
enced the GTN-mediated dilation.
Moreover, Asp/Asp genotype had a significantly greater carotid IMT than Glu allele carri-
ers (Asp/Asp: 0.46±0.03 vs Glu/Glu: 0.38±0.02 and Glu/Asp: 0.36±0.01, p=0.001) and a
strong inverse correlation between FMD and carotid IMT (Glu/Glu: r=-0.15, p=0.39; Glu/
Asp: r=-0.18, p=0.23; Asp/Asp: r=-0.59, p=0.02). No difference in IMT was found across
the eNOS T-786→C genotypes (CC: 0.39±0.03, TC: 0.38±0.01, and TT: 0.38±0.02,
p=0.98).
Conclusion: The eNOS Glu298→Asp polymorphism may be related to early atherogene-
sis.
1064-184 Photodynamic Therapy Reduces Atherosclerotic Plaque 
Inflammation, Induces Plaque Stabilization and 
Promotes Plaque Reduction
Ron Waksman, Pauline McEwan, Frank Kolodgie, Travis Moore, Steve Rychnovsky, 
David Hellinga, Rufus Seaborn, Renu Virmani, Washington Hospital Center, Washington, 
DC, Miravant Medical Technologies, Inc., Santa Barbara, CA
Background: Acute coronary syndromes are associated with other sites of vulnerable
plaque located in areas of insignificant stenosis. Intravascular PhotoPointTM photody-
namic therapy (PDT) using light activation of the novel photosensitizer MV0633 is a
potential treatment for these focal segments. Previous studies have shown cell depletion
of plaque macrophages at 7 days post PDT. The aim of this study is to assess the poten-
tial of PDT to prevent re-infiltration of macrophages, stabilize plaques and promote vas-
cular remodeling at 28 days.
Methods: New Zealand white rabbits (n=28) were fed a 1% cholesterol diet followed by
bilateral iliac balloon endothelial denudation. At 5 weeks post-denudation, rabbits
received photosensitizer MV0611 (3mg/kg I.V.) followed by light delivery using a Miravant
catheter-based diode laser at 8 hours post-injection. Control animals received either drug
or light alone. After PDT, rabbits received reduced cholesterol diet (0.05%) until sacrifice
at 7 and 28 days. Arteries were sectioned every 0.5cm for a total of 16 sections/artery
and morphometrically evaluated for vessel dimensions, cell poplulation and macrophage
(Ram-11) and smooth muscle alpha actin content.
Results: At 7 days post PDT, plaque nuclei number decreased (PDT 766±231 versus
control 3012±520mm2, P<0.001) including significant loss of macrophages (PDT
.37±0.13 v's 13.9±2.3% total plaque area, P<0.001). At 28 days, plaque macrophage
area continued to be reduced with PDT treatment (PDT 0.5% v's control 8.7% total
plaque area, P<0.01) and plaque area was significantly reduced by up to 44% (PDT
0.48± 0.05 v's control 0.86±0.16 mm2) with no negative or positive arterial remodeling. At
28 days, plaque smooth muscle alpha actin content significantly increased (PDT
40.38±6.8 v's control 12.9±3.6% total plaque area) despite reduced plaque area.
Conclusions: Photopoint PDT promotes plaque reduction while simultaneously stabiliz-
ing plaques by changing plaque cellular composition from predominantly macrophages
to smooth muscle cells.
1064-185 Systemic Infections Lead to Infiltration of Macrophages 
in Adventitia of Human Atherosclerotic Coronary 
Arteries: Clue to Triggering Effect of Acute Infections on 
Acute Coronary Syndromes
Mohammad Madjid, Deborah Vela, Silvio Litovsky, Ward Casscells, Unviersity of Texas-
Houston HSC, Houston, TX, Texas Heart Institute, Houston, TX
Infections affect initiation and progression of atherosclerosis and trigger destabilization of
vulnerable plaques. One third of acute myocardial infarctions follow an upper respiratory
infection. The effect of systemic infections on human coronary artery atherosclerosis is
largely unknown.
Methods: We studied the available pathology files of St. Luke's Episcopal Hospital
between 1991 and 2002. After exclusion of patients with HIV infection, cancer, and those
taking immunosuppressive drugs, 14 patients (11M, 3F, mean age: 67 yrs) with athero-
sclerosis and an acute infection prior to death (average 2 weeks) were selected. 13 pts
(9M, 4F, mean age: 65 yrs) with atherosclerosis and without infection were selected as
controls. Slides were stained with CD68 marker for macrophages (MQ). Plaque area was
defined as the area inside the internal elastic lamina. Periadventitial fat was defined as
up to 250 µm beyond the adventitia. MQ density was the number of MQ per square mm.
Mann-Whitney U and Wilcoxon Signed Ranks tests were used.
Results: There was no significant difference in percent stenosis between cases and con-
trols (67±14 vs. 55± 25, P=0.23). MQ density in plaques showed a non-significant trend
toward higher levels in pts with systemic infection (582±774 vs. 281±321, P=0.41), how-
ever, there was a significantly higher number of MQ in adventitia of coronaries in pts with
infection compared to controls (1,577±1,872 vs. 265±185, P=0.047). MQ density in peri-
adventitial fat showed a non-significant trend toward higher levels in pts with systemic
infection (776±821 vs. 212±219, P=0.085). Of interest, while MQ density in controls was
not different between plaque and adventitia areas (281±321 vs. 265±185, P=0.85), MQ
density in patients with systemic infection was significantly higher in adventitia than in
plaque area (582±774 vs. 1,577±1,872, P= 0.028).
Conclusion: This report shows for the first time that systemic infections are associated
with a significant increase in macrophage density in adventitia of human atherosclerotic
coronary arteries. This suggests a mechanism for the triggering of AMI observed follow-
ing acute infections, and offers a new therapeutic target for preventing heart attacks.
1064-186 Magnetic Resonance Imaging Detected Relationship 
Between Atherosclerotic Plaques and Shear Stress in 
Human Descending Thoracic Aorta In Vivo
Jolanda J. Wentzel, Roberto Corti, Zahi A. Fayad, Paul Wisdom, Frank Macaluso, 
Valentin Fuster, Juan J. Badimon, Mount Sinai School of Medicine, New York, NY
Background Atherosclerotic lesions preferentially develops at low shear stress (SS) loca-
tions. Although the descending aorta is known for its particular flow patterns, no previous
studies have correlated wall thickness and shear stress in the descending thoracic
aorta.Methods and results Cross sectional images of the thoracic descending aorta of 10
asymptomatic, hypercholesteremic, untreated patients were acquired utilizing a black
blood sequence on a 1.5T clinical MRI system with a slice thickness of 5 mm and cross
sectional resolution of 0.8 mm x0.8 mm. Atherosclerotic plaques were detected and the
average wall thickness (WT) derived per quadrant. Quadrants were subdivided in four
regions dependent on the distance (DA) from the aortic arch (region I: 1.0 cm <DA<=3
cm; Region II: 3 cm<DA<5 cm , Region III: 5 cm < DA< 7 cm , Region IV: 7 cm <DA < 9
cm). Average wall thickness was maximal at region I and statistical different from the
most distal region (3.0±0.7 mm vs 2.5±0.3 mm; P<0.05). The atherosclerotic wall thick-
ening showed a helicoidally pattern from the proximal to distal segments. Phase contrast
MRI was performed in the thoracic aorta of 8 healthy volunteers, not aware of any athero-
sclerotic disease to derive a typical shear stress distribution. From the through plane
velocity profiles the average shear stress was derived in the predefined quadrants as
mean over the cardiac cycle. The atherosclerotic wall thickness showed to be inversely
related to the shear stress : WT=-1.6*SS+3.3 [mm], r2=0.29, p<0.05). Normalization of
the wall thickness (NWT) per region, emphasized that atherosclerotic plaque build up
always starts and progresses at low shear stress regions (NWT = -0.019 * SS + 1.22 ,
r2=0.59, <0.05).Conclusion Our data showing a strong correlation between wall thicken-
ing and average low shear stress locations support the role of local hemodynamics in the
development and progression of aortic atherosclerotic lesions.
1064-187 A Novel Metabolic Effect of Oxidized Low-Density 
Lipoprotein: Downregulation of Glyceraldehyde-3-
Phosphate Dehydrogenase via a CD36 Scavenger 
Receptor-Mediated Redox Pathway Involving 5-
Lipoxygenase
Sergiy Sukhanov, Koichi Ono, Yusuke Higashi, Patrick Delafontaine, Tulane University 
Health Sciences Center, New Orleans, LA
Although oxidized LDL (OxLDL) exerts multiple proatherogenic effects, its effect on key
metabolic pathways is unexplored. Glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) catalyzes the key glycolysis reaction and plays a major role in cell metabolism.
To examine whether OxLDL regulates GAPDH in human aortic smooth muscle cells
(HASMC), we exposed HASMC to 0-100 ug/ml CuSO4-oxidized LDL or native LDL for 0-
24 h. Western analysis and real-time PCR revealed dramatic OxLDL-specific time- and
dose-dependent decreases in GAPDH mRNA and protein levels. GAPDH/actin protein
ratios in response to 60 ug/ml of OxLDL were reduced by 65±18% (n=3) and 72±6%
(n=6) at 6h and 15h, respectively. GAPDH protein expression at 24h was virtually not
detectable and GAPDH mRNA level was reduced by 45±4% (n=3) at 15h with 60 ug/ml
OxLDL. OxLDL reduced also GAPDH specific activity (52±6%, n=3) as assessed by
measurement of NADH production. Blocking antibodies to CD36 scavenger receptor (20
ug/ml) reduced OxLDL-induced apoptosis (FACS analysis/annexin V staining) by 49%
and significantly reduced OxLDL induction of peroxides and superoxides as assessed by
CDC-H2F diacetate and hydroethidine assays, respectively. Furthermore, anti-CD36 anti-
body completely inhibited OxLDL-induced reduction in GAPDH protein (n=6). The antiox-
idant Trolox (250 uM) completely inhibited OxLDL-specific peroxide, superoxide
production (n=8) and decrease in GAPDH protein (n=3). Inhibition of cyclooxygenase-2
(NS-398, 10 uM) did not block OxLDL induction of superoxides nor reduction in GAPDH
expression whereas 5 uM NDGA, a specific 5-lipoxygenase blocker, markedly inhibited
OxLDL induction of superoxides (74±7%, n=8), peroxides (38±4%, n=8) and completely
blocked OxLDL downregulation of GAPDH. In conclusion, OxLDL downregulates
GAPDH mRNA, protein levels and enzyme activity in HASMC. This effect is mediated in
large part via the CD36 scavenger receptor and a redox signaling pathway involving 5-
lipoxygenase and contributes to the pro-apoptotic effect of OxLDL. These findings pro-
vide novel insights into metabolic effects of OxLDL on the vasculature and have major
implications for understanding mechanisms of atherogenesis.
